“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Systemic mastocytosis: overview and new insights in prognosis and therapy

€3.03

SKU: product-article-20998 Category: General

Description
Reviews (0)

Description

Systemic mastocytosis: overview and new insights in prognosis and therapy

Reviews

There are no reviews yet.

Be the first to review “Article: Systemic mastocytosis: overview and new insights in prognosis and therapy”

You must be logged in to post a review.

Top

Article: Systemic mastocytosis: overview and new insights in prognosis and therapy

Description

Reviews

Related products

Article: Calendar of events

Article: Highlights in respiratory oncology

Article: Calendar of events

Article: Highlights in digestive oncology